Steve DeMattos

Characterization of the human dopamine D3 receptor expressed in transfected cell lines

Robert G. MacKenzie, Donald VanLeeuwen, Thomas A. Pugsley et al. · European Journal of Pharmacology Molecular Pharmacology · 1994 · 120 citations

Life Sciences, Neuroscience, Pharmacology +13

Evaluation of the safety, efficacy, and mechanism of action of obexelimab for the treatment of patients with IgG4-related disease: an open-label, single-arm, single centre, phase 2 pilot trial

Cory A. Perugino, Zachary S. Wallace, Debra Zack et al. · The Lancet Rheumatology · 2023 · 66 citations

Life Sciences, Immunology, Internal Medicine +11

Behavioral and neurochemical changes in the dopaminergic system after repeated cocaine administration

Lynne H. Claye, Hyacinth C. Akunne, M. Duff Davis et al. · Molecular Neurobiology · 1995 · 41 citations

Life Sciences, Neurobiology, Neuroscience +16

5,7-Dihydro-3-[2-[1-(phenylmethyl)-4-piperidinyl]ethyl]-6H-pyrrolo[3,2-f]-1,2-benzisoxazol-6-one: A Potent and Centrally-Selective Inhibitor of Acetylcholinesterase

Todd W. Butler, Douglas S. Chapin, Y L Chen et al. · Journal of Medicinal Chemistry · 1995 · 39 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +9

Differential effects of the nonpeptide neurotensin antagonist, SR 48692, on the pharmacological effects of neurotensin agonists

Thomas A. Pugsley, Hyacinth C. Akunne, Steven Z. Whetzel et al. · Peptides · 1995 · 33 citations

Medicine, Neuroscience, Pharmacology +9